Fig. 1 · Structure
Documents & Downloads
Akuammidine
Opioid Receptor Inhibitor
Akuammidine is an opioid receptor inhibitor primarily targeting μ-opioid binding sites, exhibiting Ki values of 0.6, 2.4, and 8.6 µM at μ-, σ-, and κ-opioid receptors, respectively. This compound demonstrates notable anti-inflammatory and anti-asthmatic activities, making it a valuable tool for research in pain management and respiratory conditions. Its specificity for μ-opioid receptors supports investigations into the therapeutic potential and mechanisms of action of opioid analgesics.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 639-36-1 |
| Applications | Opioid Receptor Inhibitor |
| Formula | C21H24N2O3 |
| Molecular Weight | 352.43 |
| SMILES | O=C([C@@]1([C@@](CC2=C3NC4=CC=CC=C24)([H])[N@@](C/5)[C@H]3C[C@H]1C5=C/C)CO)OC |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.